Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 1–15 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1698 Featured Comprehensive Hereditary Cancer Panel (154 Genes) Test This test evaluates 154 genes for inherited mutations associated with an increased risk of hereditary cancers.	Peripheral Whole Blood	4–6 weeks	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants", "Insertions", "Deletions", "Copy number alterations"] Parameters [] Preparation ["No fasting or special preparation is required"] Indications ["Individuals with a strong family history of cancer", "Individuals with multiple primary malignancies", "Individuals with early-onset tumors", "Individuals recommended by a specialist"] Measurement technique Confirm with laboratory Codes LOINC: 91847-5 ICD-10: Z15.01, Z15.02, Z15.03, Z15.04, Z15.09 Clinical summary This test evaluates 154 genes for inherited mutations associated with an increased risk of hereditary cancers.
TEST-367 12S rRNA (MTRNR1) Gene Sequencing Test This test detects specific mitochondrial DNA variants (m.1555A>G, m.1494C>T) associated with increased risk of aminoglycoside-induced ototoxicity.	Whole Blood (3 mL EDTA) or Extracted DNA (≥20 ng/μL)	14 Business Days	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MTRNR1 gene variants (m.1555A>G, m.1494C>T)", "Risk of aminoglycoside-induced ototoxicity"] Parameters [] Preparation [] Indications ["Risk assessment before aminoglycoside therapy", "Family history of hearing loss", "Pre-conception carrier screening in high-risk populations"] Measurement technique Confirm with laboratory Codes LOINC: 53576-1 ICD-10: H90.3, Z14.8, Z82.2 Clinical summary This test detects specific mitochondrial DNA variants (m.1555A>G, m.1494C>T) associated with increased risk of aminoglycoside-induced ototoxicity.
TEST-260 16S rRNA V3-V4 Microbiome Sequencing Test This test sequences and identifies bacterial species present in a DNA sample by targeting the V3-V4 hypervariable region of the 16S ribosomal RNA gene.	Peripheral Whole Blood	4 weeks with comprehensive bioinformatics report	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Bacterial species identification", "Taxonomic profile of the bacterial microbiome"] Parameters [] Preparation ["Avoid antibiotics or probiotics for at least 4 weeks prior to whole blood collection.", "Disclose recent antibiotic or probiotic use.", "Follow physician's instructions for any medication adjustments."] Indications ["Oncology research (gut-tumor axis)", "Longitudinal microbiome studies", "Validation of pre-analytical workflows for biobanking"] Measurement technique Confirm with laboratory Codes LOINC: 82093-2 ICD-10: Z13.89 Clinical summary This test sequences and identifies bacterial species present in a DNA sample by targeting the V3-V4 hypervariable region of the 16S ribosomal RNA gene.
TEST-373 18S rRNA Sequencing Test This test identifies fungal, parasitic, and microbiome species by analyzing the 18S ribosomal RNA gene.	Whole blood (EDTA) or extracted DNA	2 weeks	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["18S ribosomal RNA gene sequences", "Species-level identification of fungi, parasites, and microbiome"] Parameters [] Preparation ["No dietary or medication changes are required unless specifically instructed by your doctor."] Indications ["Diagnosis of fungal infections", "Diagnosis of parasitic infections", "Microbiome analysis", "Oncology patient monitoring", "Infectious disease diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 103255-9 ICD-10: B49 Clinical summary This test identifies fungal, parasitic, and microbiome species by analyzing the 18S ribosomal RNA gene.
TEST-1881 1p & 19q Test This diagnostic test evaluates for the co-deletion of chromosome arms 1p and 19q in glioma tissue samples.	Formalin-fixed paraffin-embedded (FFPE) tumour tissue block or 10 unstained slides	7–8 working days	1,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Co-deletion of chromosome arms 1p and 19q"] Parameters [] Preparation ["No fasting required", "A tumour tissue sample obtained via biopsy is needed", "A valid doctor’s prescription is required"] Indications ["Diagnosis and classification of glioma, particularly oligodendroglioma", "Guiding personalized treatment decisions", "Predicting chemotherapy response"] Measurement technique Confirm with laboratory Codes LOINC: 49296-6 ICD-10: C71.9 Clinical summary This diagnostic test evaluates for the co-deletion of chromosome arms 1p and 19q in glioma tissue samples.
TEST-45 2x150 HiSeq Sequencing (Single Lane) Test This test provides a comprehensive analysis of the entire genome using high-throughput sequencing technology.	Whole Blood (EDTA) or Extracted DNA	3 weeks (standard); 10 to 14 business days (expedited)	25,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants", "Insertions", "Deletions", "Copy number alterations", "Structural rearrangements", "Whole genome coverage"] Parameters [] Preparation ["Fasting is not required"] Indications ["Oncogenomic profiling", "Inherited disease screening", "Pharmacogenomics", "Anti-aging research"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Z13.71 Clinical summary This test provides a comprehensive analysis of the entire genome using high-throughput sequencing technology.
TEST-2712 4H Syndrome Genetic Sequencing Test This test identifies genetic variants associated with 4H Syndrome, a rare disorder characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism.	Whole Blood	40 working days	2,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in POLR3A gene", "Pathogenic variants in POLR3B gene", "Copy number variants"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Clinical suspicion of 4H syndrome", "Patients presenting with characteristic features of 4H syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 51961-7 ICD-10: E23.0, G37.8, K00.0 Clinical summary This test identifies genetic variants associated with 4H Syndrome, a rare disorder characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism.
TEST-86 5-Fluorouracil (5-FU) Toxicity Test This test evaluates the DPYD gene for variants associated with reduced 5-Fluorouracil metabolism and increased risk of severe toxicity.	4 mL Whole Blood (Lavender-top EDTA)	5–7 working days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DPYD gene variants", "5-Fluorouracil metabolism capacity"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Patients scheduled for 5-Fluorouracil chemotherapy", "Colorectal cancer", "Breast cancer", "Head/neck cancer"] Measurement technique Confirm with laboratory Codes LOINC: 92730-6 ICD-10: Z01.89, Z15.89, Z79.899 Clinical summary This test evaluates the DPYD gene for variants associated with reduced 5-Fluorouracil metabolism and increased risk of severe toxicity.
TEST-1877 AAAS Full Gene Sequence Analysis (Allogrove Syndrome) Test This test sequences the entire AAAS gene to detect mutations associated with Allogrove (Triple A) Syndrome.	Peripheral Whole Blood; Prenatal: Amniotic Fluid, Chorionic Villi, or Cord Blood	2–3 Weeks	4,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AAAS gene sequence", "Point mutations", "Small insertions", "Small deletions"] Parameters [] Preparation [] Indications ["Suspected Allogrove (Triple A) Syndrome", "Family history of Allogrove Syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 93307-9 ICD-10: Q87.8, E25.8, Z13.79 Clinical summary This test sequences the entire AAAS gene to detect mutations associated with Allogrove (Triple A) Syndrome.
TEST-4036 AARS1 Gene (CMT2N) Genetic Test This test evaluates the AARS1 gene for pathogenic variants associated with autosomal dominant axonal Charcot-Marie-Tooth disease type 2N (CMT2N).	Peripheral whole blood	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AARS1 gene variants", "Single nucleotide variants", "Small insertions/deletions", "Copy number variants (CNV)"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counseling", "Three-generation pedigree chart required"] Indications ["Clinical suspicion of CMT2N", "Family history of CMT2N", "Need for definitive diagnosis of inherited neuropathy"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G60.0 Clinical summary This test evaluates the AARS1 gene for pathogenic variants associated with autosomal dominant axonal Charcot-Marie-Tooth disease type 2N (CMT2N).
TEST-4798 AARS2 Gene Leukoencephalopathy with Ovarian Failure Genetic Test This genetic test identifies pathogenic variants in the AARS2 gene associated with progressive leukoencephalopathy and ovarian failure.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AARS2 gene"] Parameters [] Preparation ["No fasting required", "Ensure hydration", "Disclose all current medications"] Indications ["Suspected AARS2-related leukoencephalopathy", "Ovarian insufficiency with neurological symptoms", "Family planning in affected families"] Measurement technique Confirm with laboratory Codes LOINC: 81323-7 ICD-10: G93.8 Clinical summary This genetic test identifies pathogenic variants in the AARS2 gene associated with progressive leukoencephalopathy and ovarian failure.
TEST-6226 AASS Gene Hyperlysinemia Type 1 Genetic Test This test identifies pathogenic variants within the AASS gene, confirming a diagnosis of Hyperlysinemia Type 1.	Peripheral whole blood	21–28 calendar days from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AASS gene", "Coding region and intron-exon boundaries of the AASS gene"] Parameters [] Preparation ["No special fasting or dietary preparation required"] Indications ["Suspected Hyperlysinemia Type 1", "Persistently elevated plasma lysine", "Family history of Hyperlysinemia Type 1", "Carrier testing in relatives of affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E72.3 Clinical summary This test identifies pathogenic variants within the AASS gene, confirming a diagnosis of Hyperlysinemia Type 1.
TEST-5892 AASS Gene Saccharopinuria Genetic Test This genetic test identifies pathogenic variants in the AASS gene, which are responsible for causing saccharopinuria, a rare inherited metabolic disorder.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AASS gene", "Single-nucleotide variants", "Insertions/deletions (indels)", "Copy number changes"] Parameters [] Preparation ["Fasting is not mandatory", "Provide a complete list of current medications, supplements, and dietary therapies"] Indications ["Diagnostic workup for suspected saccharopinuria", "Carrier screening for family members", "Prenatal planning guidance"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: E72.3 Clinical summary This genetic test identifies pathogenic variants in the AASS gene, which are responsible for causing saccharopinuria, a rare inherited metabolic disorder.
TEST-6387 ABAT Gene GABA-Transaminase Deficiency Genetic Test This genetic test identifies pathogenic variants within the ABAT gene, confirming or ruling out GABA-transaminase deficiency.	Whole Blood (Peripheral)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ABAT gene", "GABA-transaminase deficiency"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Symptomatic paediatric and adult patients", "At-risk family members", "Proactive carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 94853-3 ICD-10: E72.89 Clinical summary This genetic test identifies pathogenic variants within the ABAT gene, confirming or ruling out GABA-transaminase deficiency.
TEST-6306 ABCA1 Gene HDL Deficiency Type 2 Genetic Test This genetic test analyzes the ABCA1 gene to identify mutations causing familial HDL deficiency type 2 (Tangier disease). It helps confirm the diagnosis and assess cardiovascular r...	Peripheral whole blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ABCA1 gene sequence", "Single nucleotide variants", "Small insertions/deletions", "Splice-site mutations"] Parameters [] Preparation ["No specific fasting required.", "Inform phlebotomist of any known coagulopathy."] Indications ["Diagnosis of familial HDL deficiency type 2 (Tangier disease)", "Family cascade screening for ABCA1 mutations", "Assessment of cardiovascular risk in individuals with severely low HDL"] Measurement technique Confirm with laboratory Codes LOINC: 21301-0 ICD-10: E78.6 Clinical summary This genetic test analyzes the ABCA1 gene to identify mutations causing familial HDL deficiency type 2 (Tangier disease). It helps confirm the diagnosis and assess cardiovascular risk.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories